Baseline characteristics of the study population in the Diabetes Atherosclerosis Intervention Study (DAIS)
- 1 November 1999
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 84 (9) , 1004-1010
- https://doi.org/10.1016/s0002-9149(99)00488-9
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Cardiovascular Events and Their Reduction With Pravastatin in Diabetic and Glucose-Intolerant Myocardial Infarction Survivors With Average Cholesterol LevelsCirculation, 1998
- Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial InfarctionNew England Journal of Medicine, 1998
- Diabetes Atherosclerosis Intervention Study (DAIS): Quantitative coronary angiographic analysis of coronary artery atherosclerosisCatheterization and Cardiovascular Diagnosis, 1998
- Cardiovascular Outcomes in Type 2 Diabetes: A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) StudyDiabetes Care, 1998
- Impact of Diabetes on Mortality After the First Myocardial InfarctionDiabetes Care, 1998
- Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)Diabetes Care, 1997
- The Diabetes Atherosclerosis Intervention Study (DAIS): a study conducted in cooperation with the World Health OrganizationDiabetologia, 1996
- Comparison of European and USA guidelines for prevention of coronary heart diseaseAtherosclerosis, 1994
- The dyslipoproteinemias of diabetesAtherosclerosis, 1994
- The Prospective Cardiovascular Münster (PROCAM) study: Prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart diseaseAmerican Heart Journal, 1988